Dr. Bruce G. Pollock, MD, PhD, FRCP(C), FCP is Vice President of Research and Director of the Campbell Family Mental Health Research Institute at CAMH, and Professor of Psychiatry and Pharmacology at the University of Toronto.
Dr. Pollock has received numerous awards and honours. He received the 2017 Canadian Academy of Geriatric Psychiatry (CAGP) Award for Outstanding Contributions in Geriatric Psychiatry. He was honoured with the designation of Distinguished Fellow of the Canadian Psychiatric Association (CPA) in 2015, and Distinguished Life Fellow of the American Psychiatric Association (APA) in 2016. He has received the Distinguished Investigator Award of the American Association for Geriatric Psychiatry (AAGP) and served as President of the AAGP, the first Canadian to serve in this position. Dr. Pollock has also been awarded APA Jack Weinberg Memorial Award for excellence in Geriatric Psychiatry, the Award for Research in Geriatric Psychiatry by the American College of Psychiatrists, and the William B. Abrams Award in Geriatric Clinical Pharmacology from the American Society for Clinical Pharmacology and Therapeutics (ASCPT).
Areas of Research
Dr. Pollock is internationally recognized for his work in geriatric clinical psychopharmacology. His overarching research objective is improved therapeutic approaches to geriatric care and his work includes clinical studies examining neurochemical selectivity, pharmacokinetics, and neurophysiological-therapeutic effects of conventional or newly derived/modified agents for the treatment of depression and the behavioural disturbances of dementia. Dr. Pollock is listed by ISI as among the 1% most cited authors in the field of geriatric psychiatry.
He has had a leadership role in numerous clinical trials, and the U.S. National Institutes of Health has continuously funded his research on psychiatric disorders in geriatric patients since 1990.
View Dr. Pollock's publications on Google Scholar.